The DOI matches its Crossref record.
Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.
Open accessAbstract
Two monoclonal antibodies, NCC-LU-35 and NCC-LU-81, have been established after immunization of mice with membrane preparations of human lung cancer Lu65 tumor xenograft cells grown in vivo and intact cells cultured in vitro, respectively. These two antibodies react specifically with a majority of human adenocarcinomas, irrespective of the host's blood group ABO status, as well as with normal tissues and erythrocytes of blood group A individuals. The antigenicity is associated with a high molecular weight mucin-like glycoprotein separated by gel filtration of Lu65 tumor extracts. The epitope of the mucin-like glycoprotein has been identified as alpha-N-acetylgalactosaminyl residue directly linked O-glycosidically to serine or threonine residues of polypeptides. This epitope was serologically detected several years ago and given the name Tn. Our identification of the epitope is based on the following results: The antigen is sensitive to alpha-N-acetylgalactosaminidase, but not to sialidase or alpha-fucosidase. Various mono- and difucosyl A determinants, either type 1 or type 2 chain, cross-react with both antibodies. The reactivity with both antibodies can be created by treatment of glycophorin A of normal erythrocytes with sialidase followed by beta-galactosidase. N-[3H]acetylgalactosamine can be released by galactose oxidase/NaB3H4 treatment from the Lu65 mucin-like glycoprotein but not from the mucin-like glycoprotein of normal colonic mucosa upon reductive beta-elimination (alkaline borohydride treatment). The antigen may be one of the tumor-associated A cross-reacting antigens occurring in a wide variety of human adenocarcinomas of hosts belonging to all ABO blood groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
(1989) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60215-8 · Cited by 1,087
Clausen, H., & Hakomori, S. (1989) · Vox Sanguinis · doi:10.1111/j.1423-0410.1989.tb03040.x · Cited by 504
Self-citationHakomori, S.-I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012540899 · Cited by 492
Self-citationHakomori, S.-I. (2001) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-1267-7_24 · Cited by 448
Self-citationSialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients
Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S.-I., & Kim, Y. S. (1990) · Cancer · doi:10.1002/1097-0142(19901101)66:9<1960::aid-cncr2820660919>3.0.co;2-x · Cited by 381
Self-citation
Metadata
- Authors
- Hirohashi, S., Clausen, H., Yamada, T., Shimosato, Y., & Hakomori, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1985-10
- Volume
- 82
- Issue
- 20
- Pages
- 7039-7043
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061503461
- Cited by
- 197
- References
- 0
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. https://app.cochat.ai/papers/10.1073/pnas.82.20.7039
- The paper
- Hirohashi, S., Clausen, H., Yamada, T., Shimosato, Y., & Hakomori, S. (1985). Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.82.20.7039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.